These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17652880)

  • 1. Quality of life improvement and long-term effects of peripheral blood mononuclear cell transplantation for severe arteriosclerosis obliterans in diabetic patients on dialysis.
    Hoshino J; Ubara Y; Hara S; Sogawa Y; Suwabe T; Higa Y; Nakanishi S; Sawa N; Katori H; Takemoto F; Fujimoto Y; Ohta E; Ohara K; Takaichi K
    Circ J; 2007 Aug; 71(8):1193-8. PubMed ID: 17652880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutical potential of autologous peripheral blood mononuclear cell transplantation in patients with type 2 diabetic critical limb ischemia.
    Ozturk A; Kucukardali Y; Tangi F; Erikci A; Uzun G; Bashekim C; Sen H; Terekeci H; Narin Y; Ozyurt M; Ozkan S; Sayan O; Rodop O; Nalbant S; Sıldıroglu O; Yalnız FF; Senkal IV; Sabuncu H; Oktenli C
    J Diabetes Complications; 2012; 26(1):29-33. PubMed ID: 22240264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes.
    Huang P; Li S; Han M; Xiao Z; Yang R; Han ZC
    Diabetes Care; 2005 Sep; 28(9):2155-60. PubMed ID: 16123483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Autologous peripheral blood stem cells transplantation in treatment of 62 cases of lower extremity ischemic disorder].
    Yang XF; Wu YX; Wang HM; Xu YF; Lü X; Zhang YB; Wang F; Zhang Y
    Zhonghua Nei Ke Za Zhi; 2005 Feb; 44(2):95-8. PubMed ID: 15840218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome From a Randomized Controlled Clinical Trial　- Improvement of Peripheral Arterial Disease by Granulocyte Colony-Stimulating Factor-Mobilized Autologous Peripheral-Blood-Mononuclear Cell Transplantation (IMPACT).
    Horie T; Yamazaki S; Hanada S; Kobayashi S; Tsukamoto T; Haruna T; Sakaguchi K; Sakai K; Obara H; Morishita K; Saigo K; Shintani Y; Kubo K; Hoshino J; Oda T; Kaneko E; Nishikido M; Ioji T; Kaneda H; Fukushima M;
    Circ J; 2018 Jul; 82(8):2165-2174. PubMed ID: 29877199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical study of therapeutic angiogenesis by autologous peripheral blood stem cell (PBSC) transplantation in 92 patients with critically ischemic limbs.
    Kawamura A; Horie T; Tsuda I; Abe Y; Yamada M; Egawa H; Iida J; Sakata H; Onodera K; Tamaki T; Furui H; Kukita K; Meguro J; Yonekawa M; Tanaka S
    J Artif Organs; 2006; 9(4):226-33. PubMed ID: 17171401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic neovascularization by transplantation of mobilized peripheral blood mononuclear cells for limb ischemia. A comparison between CD34+ and CD34- mononuclear cells.
    Li S; Zhou B; Han ZC
    Thromb Haemost; 2006 Feb; 95(2):301-11. PubMed ID: 16493493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous peripheral blood mononuclear cell implantation for patients with peripheral arterial disease improves limb ischemia.
    Ishida A; Ohya Y; Sakuda H; Ohshiro K; Higashiuesato Y; Nakaema M; Matsubara S; Yakabi S; Kakihana A; Ueda M; Miyagi C; Yamane N; Koja K; Komori K; Takishita S
    Circ J; 2005 Oct; 69(10):1260-5. PubMed ID: 16195628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous transplantation of peripheral blood stem cells as an effective therapeutic approach for severe arteriosclerosis obliterans of lower extremities.
    Huang PP; Li SZ; Han MZ; Xiao ZJ; Yang RC; Qiu LG; Han ZC
    Thromb Haemost; 2004 Mar; 91(3):606-9. PubMed ID: 14983238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised comparison of G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow-mononuclear cells for the treatment of patients with lower limb arteriosclerosis obliterans.
    Huang PP; Yang XF; Li SZ; Wen JC; Zhang Y; Han ZC
    Thromb Haemost; 2007 Dec; 98(6):1335-42. PubMed ID: 18064333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical features and treatment of arteriosclerosis obliterans with diabetes.
    Tsushima N; Matsuo H; Hayashi T; Homma S
    Diabetes; 1996 Jul; 45 Suppl 3():S101-4. PubMed ID: 8674871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of low-density lipoprotein apheresis on plasma matrix metalloproteinase-9 and serum tissue inhibitor of metalloproteinase-1 levels in diabetic hemodialysis patients with arteriosclerosis obliterans.
    Nakamura T; Matsuda T; Suzuki Y; Ueda Y; Koide H
    ASAIO J; 2003; 49(4):430-4. PubMed ID: 12918586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of autologous progenitor cell transplantation for therapeutic angiogenesis in patients with critical limb ischemia.
    Kajiguchi M; Kondo T; Izawa H; Kobayashi M; Yamamoto K; Shintani S; Numaguchi Y; Naoe T; Takamatsu J; Komori K; Murohara T
    Circ J; 2007 Feb; 71(2):196-201. PubMed ID: 17251666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term clinical outcomes for patients with lower limb ischemia implanted with G-CSF-mobilized autologous peripheral blood mononuclear cells.
    Horie T; Onodera R; Akamastu M; Ichikawa Y; Hoshino J; Kaneko E; Iwashita C; Ishida A; Tsukamoto T; Teramukai S; Fukushima M; Kawamura A;
    Atherosclerosis; 2010 Feb; 208(2):461-6. PubMed ID: 19720375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow mononuclear cells versus G-CSF-mobilized peripheral blood mononuclear cells for treatment of lower limb ASO: pooled analysis for long-term prognosis.
    Onodera R; Teramukai S; Tanaka S; Kojima S; Horie T; Matoba S; Murohara T; Matsubara H; Fukushima M; ;
    Bone Marrow Transplant; 2011 Feb; 46(2):278-84. PubMed ID: 20479708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transplantation of autologous peripheral blood stem cells for the treatment of lower limb arteriosclerosis obliterans].
    Huang PP; Li SZ; Han MZ; Xiao ZJ; Yang RC; Qiu LG; Qian GQ; Fu RM; Zheng YL; Liu CH; Xu XQ; Li JF; Han ZC
    Zhonghua Xue Ye Xue Za Zhi; 2003 Jun; 24(6):308-11. PubMed ID: 12859867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative study on autologous implantation between bone marrow stem cells and peripheral blood stem cells for treatment of lower limb ischemia].
    Gu Y; Zhang J; Qi L
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Jul; 21(7):675-8. PubMed ID: 17694651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Autologous transplantation of peripheral blood stem cell in treatment of critical limb ischemia].
    Zhang HK; Li M; Feng H
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2007 Jul; 36(4):360-3. PubMed ID: 17717827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiographic demonstration of neoangiogenesis after intra-arterial infusion of autologous bone marrow mononuclear cells in diabetic patients with critical limb ischemia.
    Ruiz-Salmeron R; de la Cuesta-Diaz A; Constantino-Bermejo M; Pérez-Camacho I; Marcos-Sánchez F; Hmadcha A; Soria B
    Cell Transplant; 2011; 20(10):1629-39. PubMed ID: 22289660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of autologous transplantation of G-CSF-mobilized peripheral blood mononuclear cells and Panax notoginseng saponins in the treatment of unreconstructable critical limb ischemia.
    Wang X; Jiang L; Wang X; Yin F; Li G; Feng X; Wang K; Sun S
    Ann Vasc Surg; 2014 Aug; 28(6):1501-12. PubMed ID: 24632316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.